Last week, the Drug Enforcement Agency declined (again) to reschedule marijuana opting instead to keep it listed as a dangerous drug. The DEA is receiving an avalanche of public criticism about their decision, including from Dr. Sanjay Gupta who took the agency to task on CNN.com.
In his article published Friday, the well known physician and chief medical correspondent vocalized his disappointment in the DEA's decision. He was especially critical about the agency's decision to lift restrictions on cannabis research while failing to reschedule cannabis from its current Schedule 1 classification.
"Imagine a product that is in high demand but kept behind a locked door. In response to the demand for the product, someone makes a baffling decision to make more of it but still never unlocks the door," wrote Gupta. "Marijuana is that product, and its Schedule I designation is that locked door. That is the predicament of medical marijuana."
The DEA's decision means they still think of cannabis as one of the world's most dangerous drugs with no medical value.
Dr. Gupta was also quick to call out the Administration's hypocrisy on handling marijuana's absurd classification. "While the DEA continues to dig in on Schedule I status, deeming no medical benefit, the U.S. Department of Health and Human Services simultaneously holds a patent on cannabinoids for a wide range of medicinal purposes," Gupta said.
"The DEA continues to place marijuana alongside heroin and LSD as drugs with high abuse potential even though the DEA's own former chief administrative law judge, Francis Young, disagreed with this," he added.
H/T SF Gate